China's Shanghai Pharmaceuticals sales revenues 2022, by category
In 2022, Shanghai Pharmaceuticals Holding generated around 26.76 billion yuan of revenues from its pharmaceutical products. Cardiology and systematic anti-infectives were the most important business fields for the company's sales. The enterprise is one of the largest national pharmaceutical groups in China which owns over 1,700 pharmacies.